Showing results (741-750 of 764) with videos related to

Sort By:
Pageof 77
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2022
Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomasG Ghilardi, E A Chong, J Svoboda, et al.
Blood Advances|August 18, 2023
Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohortJackson T Bowers, Jacob Anna, Steven M Bair, et al.
Neuro-Oncology Advances|August 22, 2025
First-in-human study of an EGFRvIII x CD3 T cell bispecific antibody in the treatment of newly diagnosed glioblastomaJames R Whittle, Maria Vieito, Kristoffer Rohrberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 2, 2019
Emergence and Transmission of Drug-/Multidrug-resistant Mycobacterium leprae in a Former Leprosy Colony in the Brazilian AmazonPatrícia S Rosa, Helena R S D'Espindula, Ana C L Melo, et al.
Medical Sciences (Basel, Switzerland)|May 27, 2026
Antimicrobial Efficacy of Endogenous Blue Light Photoinactivation (400-470 nm) Against Escherichia coli: A Systematic Review of In Vitro Evidence and Clinical ImplicationsDiego Antônio C P Gomes Mello, João Pedro R Afonso, Everton Edgar Carvalho, et al.
NEJM Evidence|May 22, 2024
CAR T-Cell Immunotherapy in Minority Patients with LymphomaGuido Ghilardi, Staci Williamson, Raymone Pajarillo, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2019
In vivo selective inhibition of TRPC6 by antagonist BI 749327 ameliorates fibrosis and dysfunction in cardiac and renal diseaseBrian Leei Lin, Damian Matera, Julia F Doerner, et al.
Blood Advances|December 19, 2023
Bendamustine lymphodepletion before axicabtagene ciloleucel is safe and associates with reduced inflammatory cytokinesGuido Ghilardi, Luca Paruzzo, Jakub Svoboda, et al.
Nature Communications|May 15, 2026
Naïve CD4+ T-cells and disease status at CART infusion correlate with clinical outcomes in real-world large B-cell lymphoma patients receiving second-line CAR T therapyMichael Schneider, Luca Paruzzo, Federico Stella, et al.
Cancer Discovery|July 29, 2022
Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against CancerYong Gu Lee, Puneeth Guruprasad, Guido Ghilardi, et al.
Pageof 77